The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Lewis, Henry Thomas John
    Director born in April 1988
    Individual (4 offsprings)
    Officer
    2019-08-01 ~ now
    OF - Director → CIF 0
  • 2
    Lewis, Gary Stephen
    Pharmacist born in February 1960
    Individual (8 offsprings)
    Officer
    ~ now
    OF - Director → CIF 0
    Mr Gary Stephen Lewis
    Born in February 1960
    Individual (8 offsprings)
    Person with significant control
    2016-08-01 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 3
    Lewis, Carmen
    Secretary Administrator born in January 1965
    Individual (8 offsprings)
    Officer
    ~ now
    OF - Director → CIF 0
    Lewis, Carmen
    Secretary Administrator
    Individual (8 offsprings)
    Officer
    ~ now
    OF - Secretary → CIF 0
    Mrs Carmen Lewis
    Born in January 1965
    Individual (8 offsprings)
    Person with significant control
    2016-08-01 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 4
    Lewis, Thomas William
    Director born in December 1989
    Individual (4 offsprings)
    Officer
    2019-08-01 ~ now
    OF - Director → CIF 0
  • 5
    Dancer, Christopher Stephen
    Managing Director born in September 1977
    Individual (2 offsprings)
    Officer
    2022-09-28 ~ now
    OF - Director → CIF 0
Ceased 3
  • 1
    Maxim, Barry William
    Accountant born in July 1938
    Individual
    Officer
    1995-05-01 ~ 2001-11-13
    OF - Director → CIF 0
  • 2
    M & N GROUP LIMITED - 1999-10-04
    The Quadrant, 118 London Road, Kingston Upon Thames, Surrey
    Active Corporate (5 parents, 183 offsprings)
    Equity (Company account)
    1 GBP2024-12-31
    Officer
    1992-02-24 ~ 1992-03-04
    PE - Nominee Secretary → CIF 0
  • 3
    2 Duke Street, St James's, London
    Active Corporate (4 parents, 4 offsprings)
    Officer
    1992-02-24 ~ 1992-03-04
    PE - Nominee Director → CIF 0
parent relation
Company in focus

A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY

Previous name
MAYLAKE LIMITED - 1995-05-17
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
502023-05-01 ~ 2024-04-30
522022-05-01 ~ 2023-04-30
Turnover/Revenue
55,982,183 GBP2023-05-01 ~ 2024-04-30
56,973,458 GBP2022-05-01 ~ 2023-04-30
Cost of Sales
-49,624,679 GBP2023-05-01 ~ 2024-04-30
-50,826,126 GBP2022-05-01 ~ 2023-04-30
Gross Profit/Loss
6,357,504 GBP2023-05-01 ~ 2024-04-30
6,147,332 GBP2022-05-01 ~ 2023-04-30
Administrative Expenses
-4,347,820 GBP2023-05-01 ~ 2024-04-30
-3,258,996 GBP2022-05-01 ~ 2023-04-30
Operating Profit/Loss
2,009,684 GBP2023-05-01 ~ 2024-04-30
2,888,336 GBP2022-05-01 ~ 2023-04-30
Other Interest Receivable/Similar Income (Finance Income)
244,215 GBP2023-05-01 ~ 2024-04-30
203,461 GBP2022-05-01 ~ 2023-04-30
Profit/Loss on Ordinary Activities Before Tax
2,252,476 GBP2023-05-01 ~ 2024-04-30
3,090,194 GBP2022-05-01 ~ 2023-04-30
Profit/Loss
1,592,889 GBP2023-05-01 ~ 2024-04-30
2,562,376 GBP2022-05-01 ~ 2023-04-30
Property, Plant & Equipment
469,406 GBP2024-04-30
473,864 GBP2023-04-30
Fixed Assets
469,406 GBP2024-04-30
473,864 GBP2023-04-30
Total Inventories
4,262,110 GBP2024-04-30
4,512,674 GBP2023-04-30
Debtors
Current
12,473,622 GBP2024-04-30
11,919,404 GBP2023-04-30
Cash at bank and in hand
3,828,006 GBP2024-04-30
7,676,906 GBP2023-04-30
Current Assets
20,563,738 GBP2024-04-30
24,108,984 GBP2023-04-30
Creditors
Current, Amounts falling due within one year
-4,527,114 GBP2024-04-30
-8,047,063 GBP2023-04-30
Net Current Assets/Liabilities
16,036,624 GBP2024-04-30
16,061,921 GBP2023-04-30
Total Assets Less Current Liabilities
16,506,030 GBP2024-04-30
16,535,785 GBP2023-04-30
Creditors
Non-current, Amounts falling due after one year
-24,566 GBP2024-04-30
-31,234 GBP2023-04-30
Net Assets/Liabilities
16,369,022 GBP2024-04-30
16,396,273 GBP2023-04-30
Equity
Called up share capital
51,080 GBP2024-04-30
51,080 GBP2023-04-30
51,080 GBP2022-05-01
Retained earnings (accumulated losses)
16,317,942 GBP2024-04-30
16,345,193 GBP2023-04-30
15,961,957 GBP2022-05-01
Equity
16,369,022 GBP2024-04-30
16,396,273 GBP2023-04-30
16,013,037 GBP2022-05-01
Profit/Loss
Retained earnings (accumulated losses)
1,592,889 GBP2023-05-01 ~ 2024-04-30
2,562,376 GBP2022-05-01 ~ 2023-04-30
Dividends Paid
Retained earnings (accumulated losses)
-1,620,140 GBP2023-05-01 ~ 2024-04-30
-2,179,140 GBP2022-05-01 ~ 2023-04-30
Dividends Paid
-1,620,140 GBP2023-05-01 ~ 2024-04-30
-2,179,140 GBP2022-05-01 ~ 2023-04-30
Audit Fees/Expenses
22,375 GBP2023-05-01 ~ 2024-04-30
18,750 GBP2022-05-01 ~ 2023-04-30
Wages/Salaries
1,816,217 GBP2023-05-01 ~ 2024-04-30
1,705,496 GBP2022-05-01 ~ 2023-04-30
Social Security Costs
237,288 GBP2023-05-01 ~ 2024-04-30
201,635 GBP2022-05-01 ~ 2023-04-30
Staff Costs/Employee Benefits Expense
2,780,164 GBP2023-05-01 ~ 2024-04-30
1,955,771 GBP2022-05-01 ~ 2023-04-30
Director Remuneration
426,917 GBP2023-05-01 ~ 2024-04-30
326,949 GBP2022-05-01 ~ 2023-04-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
4,164 GBP2023-05-01 ~ 2024-04-30
42,224 GBP2022-05-01 ~ 2023-04-30
Tax Expense/Credit at Applicable Tax Rate
563,119 GBP2023-05-01 ~ 2024-04-30
587,137 GBP2022-05-01 ~ 2023-04-30
Dividends Paid on Shares
1,620,140 GBP2023-05-01 ~ 2024-04-30
2,179,140 GBP2022-05-01 ~ 2023-04-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
834,161 GBP2024-04-30
780,283 GBP2023-04-30
Motor vehicles
537,873 GBP2024-04-30
575,603 GBP2023-04-30
Property, Plant & Equipment - Gross Cost
1,812,601 GBP2024-04-30
1,739,720 GBP2023-04-30
Property, Plant & Equipment - Other Disposals
Motor vehicles
-85,350 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Other Disposals
-85,350 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
587,290 GBP2023-04-30
Motor vehicles
317,946 GBP2023-04-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
1,265,856 GBP2023-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
43,895 GBP2023-05-01 ~ 2024-04-30
Motor vehicles, Owned/Freehold
39,474 GBP2023-05-01 ~ 2024-04-30
Owned/Freehold
86,319 GBP2023-05-01 ~ 2024-04-30
Plant and equipment, Under hire purchased contracts or finance leases
8,890 GBP2023-05-01 ~ 2024-04-30
Under hire purchased contracts or finance leases
8,890 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Motor vehicles
-17,870 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-17,870 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
640,075 GBP2024-04-30
Motor vehicles
339,550 GBP2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,343,195 GBP2024-04-30
Property, Plant & Equipment
Plant and equipment
194,086 GBP2024-04-30
192,993 GBP2023-04-30
Motor vehicles
198,323 GBP2024-04-30
257,657 GBP2023-04-30
Plant and equipment, Under hire purchased contracts or finance leases
26,670 GBP2024-04-30
35,560 GBP2023-04-30
Under hire purchased contracts or finance leases
26,670 GBP2024-04-30
35,560 GBP2023-04-30
Finished Goods/Goods for Resale
4,262,110 GBP2024-04-30
4,512,674 GBP2023-04-30
Trade Debtors/Trade Receivables
Current
10,281,940 GBP2024-04-30
11,287,858 GBP2023-04-30
Amounts Owed by Group Undertakings
Current
1,561,210 GBP2024-04-30
Other Debtors
Current
592,972 GBP2024-04-30
594,046 GBP2023-04-30
Called-up share capital (not paid)
Current
37,500 GBP2024-04-30
37,500 GBP2023-04-30
Cash and Cash Equivalents
3,828,006 GBP2024-04-30
7,676,906 GBP2023-04-30
Trade Creditors/Trade Payables
Current
2,438,010 GBP2024-04-30
4,088,721 GBP2023-04-30
Amounts owed to group undertakings
Current
2,415,603 GBP2023-04-30
Corporation Tax Payable
Current
440,645 GBP2024-04-30
143,829 GBP2023-04-30
Taxation/Social Security Payable
Current
515,088 GBP2024-04-30
191,811 GBP2023-04-30
Finance Lease Liabilities - Total Present Value
Current
6,668 GBP2024-04-30
6,667 GBP2023-04-30
Other Creditors
Current
1,126,703 GBP2024-04-30
1,200,432 GBP2023-04-30
Creditors
Current
4,527,114 GBP2024-04-30
8,047,063 GBP2023-04-30
Finance Lease Liabilities - Total Present Value
Non-current
24,566 GBP2024-04-30
31,234 GBP2023-04-30
Creditors
Non-current
24,566 GBP2024-04-30
31,234 GBP2023-04-30
Minimum gross finance lease payments owing
31,234 GBP2024-04-30
37,901 GBP2023-04-30
Net Deferred Tax Liability/Asset
-112,442 GBP2024-04-30
-108,278 GBP2023-04-30
-66,054 GBP2022-05-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
-4,164 GBP2023-05-01 ~ 2024-04-30
-42,224 GBP2022-05-01 ~ 2023-04-30
Deferred Tax Liabilities
Accelerated tax depreciation
-112,442 GBP2024-04-30
-108,278 GBP2023-04-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
51,000 shares2024-04-30
51,000 shares2023-04-30
Par Value of Share
Class 1 ordinary share
1.002023-05-01 ~ 2024-04-30
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
10 shares2024-04-30
10 shares2023-04-30
Par Value of Share
Class 2 ordinary share
1.002023-05-01 ~ 2024-04-30
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
10 shares2024-04-30
10 shares2023-04-30
Par Value of Share
Class 3 ordinary share
1.002023-05-01 ~ 2024-04-30
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
10 shares2024-04-30
10 shares2023-04-30
Par Value of Share
Class 4 ordinary share
1.002023-05-01 ~ 2024-04-30
  • A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY
    Info
    MAYLAKE LIMITED - 1995-05-17
    Registered number 02690345
    Unit 20 & 21 Easter Industrial, Park, Ferry Lane South, Rainham, Essex RM13 9BP
    Public Limited Company incorporated on 1992-02-24 (33 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-19
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.